Psychodermatology

Psychodermatology

Volumn , Issue , 2005, Pages 1-158

  Walker, Carl ^a   Papadopoulos, Linda ^a  

^a LONDON METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79551495164     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511544170     Document Type: Book

References (545)

1. Al’Abadie, M.S.K., Kent, G.G., & Gawkrodger, D.J. (1994).The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions. British Journal of Dermatology, 130, 199–203.
2. The All Parliamentary Group on Skin (2003). Call for Evidence.
3. Beard, G.M. (1880). What Constitutes a Discovery in Science? New York.
4. Ben-Tovim, D.I., & Walker, M.K. (1995). Body image, disfigurement and disability. Journal of Psychosomatic Research, 39(3), 283–291.
5. Brown, D.P., & Fromm, E. (1987). Hypnosis and Behavioral Medicine. Hillsdale, NJ: Erlbaum.
6. Cash, T.F. (1985). Physical appearance and mental health. In: J.A. Graham & A. Kligman (Eds), Psychology of Cosmetic Treatments. New York: Praeger Scientific.
7. Cash, T.F. (1993). Body-image attitudes among obese enrollees in a commercial weight-loss program. Perceptual and Motor Skills, 77, 1099–1103.
8. Cash, T.F., & Brown, T.A. (1987). Body image in anorexia nervosa and bulimia nervosa: a review of the literature. Behavior Modification, 11, 487–521.
9. Cash, T.F., & Pruzinsky, T. (1990). Body Images: Development, Deviance and Change. New York: Guildford Publications Inc.
10. Cotterill, J.A. (1989). Psychiatry and the skin. British Journal of Hospital Medicine, 42, 401–404.
11. Cunliffe, W.J. (1986). Unemployment and acne. British Journal of Dermatology, 115, 386.
12. Dungey, R.K., & Busselmeir, T.J. (1982). Medical and psychosocial aspects of psoriasis. Health and Social Work, 5, 140–147.
13. Engel, G.L. (1977). The need for a new medical model: a challenge for biomedicine. Science, 196, 129–136.
14. Engles, W.D. (1982). Dermatologic disorders. Psychosomatics, 23, 1209–1219.
15. Goffman, E. (1968). Stigma - Notes on the Management of Spoiled Identity. Harmondsworth: Penguin Books.
16. Greismar, R.D. (1978). Emotionally triggered disease in dermatological practice. Psychiatric Annals, 8,49–56.
17. Goldberg, P., Bernstein, N., & Crosby, R. (1975). Vocational development of adolescents with burn injury. Rehabilitation Counselling Bulletin, 18, 140–146.
18. Harper, J. (1992). Vitiligo: a questionnaire study. Unpublished research.
19. Hillier, T. (1865). Handbook of Skin Disease. London: Walton & Maberly.
20. Invernizzi, G., Gala, G., Bovio, L., Conte, G., Manca, G., Polenghi, M., & Russo, R. (1988). Onset of psoriasis: the role of life events. Medical Science Research, 16, 143–144.
21. Jowett, S., & Ryan, T. (1985). Skin disease and handicap: an analysis of the impact of skin conditions. Social Science and Medicine, 20(4), 425–429.
22. Kleinman, A. (1988). The Illness Narratives: Suffering, Healing, and the Human Condition. New York: Basic Books, Inc.
23. Kleve, L., Rumsey, N., Wyn-Williams, M., & White, P. (2002). The effectiveness of cognitive- behavioural interventions provided at Outlook: a disfigurement support unit. Journal of Evaluation in Clinical Practice, 8(4), 387–395.
24. Koblenzer, C.S. (1992). Cutaneous manifestations of psychiatric disease that commonly present to the dermatologist - diagnoses and treatment. International Journal of Psychiatry in Medicine, 22(1), 47–63.
25. Koblenzer, C.S. (1983). Psychosomatic concepts in dermatology. A dermatologist-psychoanalyst’s viewpoint. Archives of Dermatology, 119(6), 501–512.
26. Lanigan, S.W., & Cotterill, J.A. (1989). Psychological disabilities amongst patients with port- wine stain. British Journal of Dermatology, 121, 209–215.
27. Leary, M.R., Rapp, S.R., Herbst, K.C., Exum, M.L., & Feldman, S.R. (1998). Interpersonal concerns and psychological difficulties of psoriasis patients: effects of disease severity and fear of negative evaluation. Health Psychology, 17, 530–536.
28. Liu, P.Y., Bondesson, L., & Johansson, W.L.O. (1996). The occurrence of cutaneous nerve endings and neuropeptides in vitiligo vulgaris: a case control study. Archives of Dermatology, 288,670–675.
29. Meehl, P.E. (1962). Schizotaxia, schizotypy, schizophrenia. American Psychologist, 17, 827–838.
30. Myers, P., & Biocca, F. (1992). The elastic body image: the effects of television advertising and programming on body image distortions in young women. Journal of Communication, 42, 108–133.
31. Noles, S.W., Cash, T.F., & Winstead, B.A. (1985). Body image, physical attractiveness, and depression. Journal of Consulting and Clinical Psychology, 53, 88–94.
32. Obermeyer, A. (1985). Psychoses and Disorders of the Skin: Psychocutaneous Medicine. Illinois: Thomas Publishing.
33. Ortonne, J.P. (1983). Vitiligo and Other Hypomelanoses of Hair and Skin. New York, Plenum Publishing.
34. Papadopoulos, L., & Bor, R. (1999). Psychological Approaches to Dermatology. BPS Books. Leicester, UK.
35. Papadopoulos, L., & Walker, C.J. (2003). Understanding Skin Problems. John Wiley & Sons Ltd. Chichester.
36. Papadopoulos, L., Bor, R., Legg, C., & Hawk, J.L.M. (1998). Impact of stressful life events on the onset of vitiligo in adults: preliminary evidence for a psychological dimension in aetiology. Clinical and Experimental Dermatology, 23(6), 243–248.
37. Papadopoulos, L., Bor, R., & Legg, C. (1999). Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive-behavioural therapy. British Journal of Medical Psychology, 72(3), 385–396.
38. Porter, J.R., Beuf, A.H., Lerner, A., & Nordlund, J. (1987). Response to cosmetic disfigurement: patients with vitiligo. Cutis, 39, 493–494.
39. Porter, J.R., Beuf, A.H., Lerner, A., & Nordlund, J. (1990). The effect of vitiligo on sexual relationships. Journal of American Academy of Dermatology, 22,221–222.
40. Robinson, E., Rumsey, N., & Partridge, J.P. (1996). An evaluation of the impact of social interaction skills training for facially disfigured people. British Journal of Plastic Surgery, 49, 281–289.
41. Root, S., Kent, G., & Al-Abadie, M. (1994). The relationship between disease severity, disability and psychological distress in patients undergoing PUVA treatment. Dermatology, 189, 234–237.
42. Rubinow, D.R., Peck, G.L., & Squillace, K.M. (1987). Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. Journal ofAmerican Academy Dermatology, 17(1), 25–32.
43. Sack, T. (1928). As cited in F.A. Whitlock. (1976). Psychophysiological Aspects of Skin Disease. London: WB Saunders Limited.
44. Sheppard, N.P., O’Loughlin, S., & Malone, J.P. (1986). Psychogenic skin disease: a review of 35 cases. British Journal of Psychiatry, 149, 636–643.
45. Strachey, J. (2001). The Complete Psychological Works of Sigmund Freud: A Case of Hysteria’, ‘Three Essays on Sexuality’ and Other Works. Vintage.
46. Taylor, S.E. (1999). Health Psychology. McGraw-Hill. New York.
47. Teshima, H., Kubo, C., & Kihara, H. (1982). Psychosomatic aspects of skin disease from the standpoint of immunology. Psychotherapy Psychosomatics, 37, 165–175.
48. Thompson, A., & Kent, G. (2001). Adjusting to disfigurement: processes involved in dealing with being visibly different. Clinical Psychology Review, 21(5), 663–682.
49. Thompson, R.A., Kent, G., & Smith, J.A. (2002). Living with vitiligo: dealing with difference. British Journal of Health Psychology, 7,213–225.
50. Tuke, D. (1884). Influence of the Mind upon the Body. London: Churchill.
51. Updike, J. (1990). Self consciousness Memoirs. London: Penguin Books.
52. Van Moffaert, M. (1992). Psychodermatology: an overview. Psychotherapy and Psychosomatics, 58, 125–136.
53. Vlassoff, C., Weiss, M., Ovuga, E.B.L., Eneanya, C., Titi Nwel, P., Sunday Babalola, S., Awedoba, A.K., Theophilus, B., Cofie, P., & Shetabi, P. (2000). Gender and the stigma or onchocercal skin disease in Africa. Social Science & Medicine, 50, 1353–1368.
54. Weinman, J., Petrie, K.J., Sharpe, N., & Walker, S. (2000). Causal attributions in patients and spouses following first-time myocardial infarction and subsequent lifestyle changes. British Journal of Health Psychology, 5, 263–273.
55. Wilson, A. (1863). As cited in F.A. Whitlock (1976). Psychophysiological Aspects of Skin Disease. London: WB Saunders Limited.
56. Winchell, S.A., & Watts, R.A. (1988). Relaxation therapies in the treatment of psoriasis and possible psychophysiologic mechanisms. Journal of the American Academy of Dermatology, 18, 101–104.
57. Adler, R., & Cohen, N. (1975). Behaviourly conditioned immunosuppression. Psychosomatic Medicine, 37, 333–340.
58. Augustin, M., & Maier, K. (2003). Psychosomatic aspects of chronic wounds. Dermatology and Psychosomatics, 4, 5–13.
59. Bernstern, J.E. (1983). Neuropeptides and the skin. In: L.E. Goldsmith (Ed.), Biochemistry and Physiology of the Skin, New York: Oxford University Press, pp. 1217–1233.
60. Biondi, M., & Zannino, L.G. (1997). Psychological stress, neuroimmunomodulation and susceptibility to infectious diseases in animals and man: a review. Psychotherapy and Psychosomatics, 66, 3–26.
61. Black, S. (1969). Mind and Body. London: Kimber, pp. 234–238.
62. Blauvelt, A., Hwang, S.T., & Udey, M.C. (2003). Allergic and immunologic diseases of the skin. Journal of Allergy and Clinical Immunology, 111(Suppl.), S560-S570.
63. Buske-Kirschbaum, A., Geiber, A., & Hellhammer, D. (2001). Psychobiological aspects of atopic dermatitis: an overview. Psychotherapy and Psychosomatics, 20, 6–16.
64. Buske-Kirschbaum, A., Jobst, S., & Psycho, D., et al. (1997). Attenuated free cortual response to psychosocial stress in children with atopic dermatitis. Psychosomatic Medicine, 59, 419–426.
65. Chrousos, G.O. (1995). The hypothalamus pituitary adrenal axis and immune-mediated inflammation. New England Journal ofMedicine, 332, 1351–1362.
66. Cormia, F.E., & Kaykendall, V. (1953). Experimental histamine pruritus: physical and environmental factors influencing development and severity. Journal of Investigative Dermatology, 20, 429–436.
67. Cullen, W. (1784). First Lives of the Practice of Physic, 4th edn. Edinburgh: Elliot.
68. Dhabar, F.S., Miller, A.H., & McEwen, B.S. (1996). Stress induced changes in blood leucocyte distribution. Role of adrenal steroid hormones. Journal of Immunology, 157, 1038–1044.
69. Esterling, B., Antoni, M., Kumar, M., & Scneiderman, N. (1990). Emotional repression, stress disclosure responses, and Epstein-Barr viral capsid antigen titres. Psychosomatic Medicine, 52,397–410.
70. Fortune, D.C., Richards, H.C., Griffith, C.E., & Main, C.J. (2002). Psychological stress, distress and disability in patients with psoriasis. British Journal of Clinical Psychology, 2, 157–174.
71. Freeman, H., & Elmadjian, F. (1947). The relationship between blood sugar and lymphocyte levels in normal and psychotic patients. Psychosomatic Medicine, 9, 226–233.
72. Freeman, E.H., Gorman, F.J., Singer, M.T., & Affelder, M.T. (1967). Personality variables and allergic skin reactivity: a cross validation study. Psychosomatic Medicine, 29, 312–322.
73. Gieler, U., Niemeler, V., Kupefer, J., & Brosig, B. (2003). Psycho physiological aspects of atopic dermatitis. In: J. Koo, & C.S. Lee (Ed.), Psychocutaneous Medicine, New York: Dekker, pp. 108–114.
74. Ginsburg, I.H., & Link, B.C. (1989). Feelings of stigmatisation in psoriasis. Journal of American Academic Dermatology, 20, 53–63.
75. Glaser, R., Sheridan, J.F., & Malarkey, W.B. (2000). Chronic stress modulates the immune response to a pneumococcal vaccine. Psychosomatic Medicine, 62, 804–807.
76. Gutierrez, M.A., Garcia, M.E., & Rodriguez, J.A., et al. (1999). HPA axis function in patient with acute rheumatoid arthritis. Journal of Rhematocology, 26, 2777–2781.
77. Hanifin, J., & Chan, S. (1999). Biochemical and immunological mechanisms in atopic dermatitis: new targets for emerging therapies. Journal of American Academic Dermatology, 41, 72–77.
78. Hazko, G., Szabo, C., & Nemeth, Z.H., et al. (1998). Stimulation of beta-adrenoreceptors inhibit endotoxin induced IL-12 production in normal and IL-10 deficient mice. Journal of Neuroimmunology, 88, 57–61.
79. Hickie, I., Bennett, B., Lloyd, A., Heath, A., & Martin, W. (1999). Complex genetic and environmental relationships between psychological distress, fatigue and immune functioning. Psychology of Medicine, 29, 269–277.
80. Hilliger, M., Wang, L., & Johansson, D. (1995). Ultra structure evidence of nerve fibres within all vital layers of the human epidermis. Journal of Investigative Dermatology, 104, 134–137.
81. Hunter, R., & MacAlpine, I. (1963). Three Hundred Years of Psychiatry, London: Oxford University Press.
82. Irwin, M. (2002). Psycho neuroimmunity of depression: clinical implications. Brain Behaviour and Immunity, 16, 1–16.
83. Jacobs, M.A., Friedman, M.A., Franklin, M.J., & Anderson, L.S. (1966). Incidence of psychosomatic predisposing factors in allergic disorders. Psychosomatic Medicine, 28, 679–695.
84. Jafarian-Tehrani, M., & Sternberg, G.M. (1999). Animal models of neuroimmune interactions in inflammatory diseases. Journal of Neuroimmunology, 100, 13–20.
85. Janner, L.D., Swartz, G.E., & Leigh, H. (1988). The relationship between repressive and defensive coping styles and monocyte, eosinophil, and serum glucose levels. Psychosomatic Medicine, 50, 567–575.
86. Kaposi, M. (1895). Pathology and Treatment of the Skin, New York: William Ward.
87. Kasl, S.V., Evans, A.S., & Neiderman, P.C. (1979). Psychosocial factors in the development of infectious mononucleosis. Psychosomatic Medicine, 41,445–466.
88. Kiecolt-Glaser, J.K., Ricker, D., George, J., Messick, G., Speicher, C.E., Garner, W., & Glaser, R. (1984). Urinary cortisol levels, cellular immunocompetency, and loneliness in psychiatric inpatients. Psychosomatic Medicine, 46, 15–24.
89. Kreuger, J.G. (1989). The immune basis for the treatment of psoriasis with new biologic agents. Journal of American Academic Dermatology, 46, 1–23.
90. Leventhal, H., Patrick, L., Leventhal, E.A., & Burns, E.A. (1998). Does stress emotion cause illness in elderly people. In: K.W. Schiae, & M.P. Lawton (Eds), Annual Review of Gerontology and Geriatrics, Vol. 17 Focus on Emotion and Adult Development. New York: Springer Publishing, pp. 138–84.
91. Leung, D.Y. (2000). Atopic dermatitis: new insights and opportunities for therapeutic intervention. Journal of Allergy and Clinical Immunology, 105, 860–876.
92. Linn, B.S., Linn, M.W., & Klimas, N.G. (1988). Effects of psychophysical stress on surgical outcome. Psychosomatic Medicine, 50, 230–244.
93. Linner, J., & Jemmee, G.B. (2001). Anxiety level and severity of skin condition and outcome of psychotherapy. International Journal of Dermatology, 40, 632–636.
94. Maes, M., Lin, A., Delmeire, L., & Bosmans, E. (1998). The effects of psychological stress on humans: increased productivity of pro-inflammatory cytokines and Th-1 like response in stress induced anxiety. Cytokine, 10, 313–318.
95. Marucha, P.T., Keicolt-Glaser, J.K., & Favagehi, M. (1998).Mucosal wound healing is impaired by examination stress. Psychosomatic Medicine, 60, 362–365.
96. Mason, J.W. (1968). Over-all normal balance as a key to endocrine function. Psychosomatic Medicine, 20, 791–808.
97. Panconesi, E., & Hautmann, C. (1996). Pathophysiology of stress in dermatology. Dermatologic Clinics, 14,319–341.
98. Pereira, D.B., Antoni, M.H., & Danielson, A., et al. (2003). Life stress and cervical squamous intraepithelial lesion in woman with HPV and HIV. Psychosomatic Medicine, 65,427–434.
99. Picardi, A., & Abeni, D. (2001). Stressful life events and skin disease: disentangling evidence from myth. Psychotherapy and Psychosomtics, 70, 118–136.
100. Pincelli, C., Haake, A.R., & Benassi, L., et al. (1997). Autocrine nerve growth factor protects human keratinocytes from apoptosis. Journal of Investigative Dermatology, 109, 751–764.
101. Raychaudhuri, S.P., & Farber, E.M. (2000). Neuroimmunologic aspects of psoriasis. Cutis, 68, 357–363.
102. Raychaudhuri, S.P., Rein, G., & Farber, E.M. (1995). Neuropathogenesis and neuropharmacology of psoriasis. International Journal of Dermatology, 34, 685–693.
103. Richards, H., Fortune, D.G., & Griffiths, C.E.M. (2001). The contribution of perceptions of stigmatisation to disability in patients with psoriasis. Journal of Psychosomatic Research, 50, 11–15.
104. Ravindran, A.V., Griffiths, J., Merali, Z., & Anisman, H. (1995). Lymphocyte subsets associated with major depression and dysthymia. Psychosomatic Medicine, 57, 555–563.
105. Sabioncello, A., Rabatic, S., Tomasic, J., & Dekaris, D. (2000). Immune, endocrine and psychological responses in civilians displaced by war. Psychosomatic Medicine, 62, 502–508.
106. Seyle, H. (1946). The general adaptive syndrome and diseases of adaptation. Journal of Clinical Endocrinology, 6, 117–230.
107. Scholzen, T., Armstrong, C.A., & Bunnett, N.W. (1998). Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune system. Experimental Dermatology, 7,81–96.
108. Singh, L., Pang, X., & Alexacos, N., et al. (1999). Acute immobilisation stress triggers skin mast cell degranulation via corticotrophin-releasing hormone, neurotensin and substance P: A link to neurogenic skin disorders. Brain Behaviour Immunology, 13,225–239.
109. Solomon, G.F., & Moss, R.H. (1964). Emotions, immunity and disease; a speculative theoretical integration. Archives of General Psychiatry, 11, 657–674.
110. Sternberg, G.M. (2001). Neuroendocrine regulation of autoimmune/inflammatory disease. Journal of Endocrinology, 169, 425–435.
111. Sullivan, R.L., Lipper, G., & Lerner, E.A. (1998). The neuro-immuno-cutaneous endocrine network; relationship of mind and skin. Archives of Dermotology, 134, 1431–1435.
112. Wang, L., Hillinger, M., & Jernberj, T., et al. (1990). Protein gene product 0.5. Immunoreactive nerve tissues and cells in human skin. Cell Tissue Research, 261, 25–33.
113. Whitlock, F.A. (1976). Psycho physiological aspects of skin disease. London, WB Sanderson, pp. 1–13.
114. Wilson, E. (1867). Diseases of the skin. London, Churchill.
115. Aktan, S., Ozmen, E., & Sanli, B. (2000). Anxiety, depression, and nature of acne vulgaris in adolescents. International Journal of Dermatology, 39, 354–357.
116. Allen, A.D. (1989). Intractable atopic eczema suggests major affective disorder: poor parenting is secondary (letter). Archives of Dermatology, 125, 567–568.
117. American Psychiatric Association Committee on Nomenclature and Statistics (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association.
118. Badoux, A., & Levy, D.A. (1994). Psychologic symptoms in asthma and chronic urticaria. Annals of Allergy, 72,229–234.
119. Calikusu, C., Yucel, B., Polat, A., & Baykal, C. (2003). The relation of psychogenic excoriation with psychiatric disorders: a comparative study. Comprehensive Psychiatry, 44, 256–261.
120. Colon, E.A., Popkin, M.K., Callies, A.L., Dessert, N.J., & Hordinsky, M.K. (1991). Lifetime prevalence of psychiatric disorders in patients with alopecia areata. Comprehensive Psychiatry, 32, 245–251.
121. Cotterill, J.A. (1981). Dermatologic non-disease: a common and potentially fatal disturbance of cutaneous body image. British Journal of Dermatology, 104, 611.
122. Cotterill, J.A., & Cunliffe, W.J. (1997). Suicide in dermatological patients. British Journal of Dermatology, 137(2), 246–250.
123. Czubalski, K., & Rudzki, E. (1977). Neuropsychic factors in physical urticaria. Dermatologica, 154, 1–4.
124. Driscoll, M.S., Rothe, M.J., Grant-Kels, J.M., & Hale, M.S. (1993). Delusional parasitosis: a dermatologie, psychiatric and pharmacologic approach. Journal of American Academy of Dermatology, 29, 1023–1033.
125. Engel, G.L. (1980). The clinical application of the biopsychosocial model. American Journal of Psychiatry, 137, 535–544.
126. Fortune, D.G., Main, C.J., O’Sullivan, T.M., & Griffiths, C.E. (1997). Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress. British Journal of Dermatology, 137, 755–760.
127. Gulec, A.T., Tanriverdi, N., Duru, C., Saray, Y., & Akcali, C. (2004). The role of psychological factors in alopecia areata and the impact of the disease on the quality of life. International Journal of Dermatology, 43, 352–356.
128. Gupta, M.A., & Gupta, A.K. (1996). Psychodermatology: an update. Journal of American Academy of Dermatology, 34, 1030–1046.
129. Gupta, M.A., & Gupta, A.K. (1998). Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. British Journal of Dermatology, 139(5), 846–850.
130. Gupta, M.A., & Gupta, A.K. (2000). Dermatological complications. European Eating Disorders Review, 8(2), 134–143.
131. Gupta, M.A., & Gupta, A.K. (2001a). Dissatisfaction with skin appearance among patients with eating disorders and non-clinical controls. British Journal of Dermatology, 145, 110–113.
132. Gupta, M.A., & Gupta, A.K. (2001b). The psychological comorbidity in acne. Clinical Dermatology, 19, 360–363.
133. Gupta, M.A., & Gupta, A.K. (2003). Psychiatric and psychological comorbidity in patients with dermatologic disorders. American Journal of Clinical Dermatology, 4(12), 833–842.
134. Gupta, M.A., Gupta, A.K., & Haberman, H.F. (1987). Dermatologic signs in anorexia nervosa and bulimia nervosa. Archives of Dermatology, 123, 1386–1390.
135. Gupta, M.A., Gupta, A.K., Kirkby, S., Weiner, H.K., Mace, T.M., Schork, N.J., Johnson, E.H., Ellis, C.N., & Voorhees, J.J. (1988). Pruritus in psoriasis: a prospective study of some psychiatric and dermatologic correlates. Archives of Dermatology, 124, 1052–1057.
136. Gupta, M.A., Gupta, A.K., Schork, N.J., Ellis, C.N., & Voorhees, J.J. (1990). Psychiatric aspects of the treatment of mild to moderate facial acne: some preliminary observations. International Journal of Dermatology, 29(10), 719–721.
137. Gupta, M.A., Gupta, A.K., Ellis, C.N., & Voorhees, J.J. (1992). Bulimia nervosa and acne may be related: a case report. Canadian Journal of Psychiatry, 37, 58–61.
138. Gupta, M.A., Schork, N.J., Gupta, A.K., Kirkby, S., & Ellis, C.N. (1993). Suicidal ideation in psoriasis. International Journal of Dermatology, 32, 188–190.
139. Gupta, M.A., Gupta, A.K., Schork, N.J., & Ellis, C.N. (1994). Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria. PsychosomaticMedicine, 56, 36–40.
140. Gupta, M.A., Gupta, A.K., Schork, N.J., & Watteel, G.N. (1995). Perceived touch deprivation and body image: some observations among eating disordered and non-clinical subjects. Journal of Psychosomatic Research, 39, 459–464.
141. Gupta, M.A., Gupta, A.K., & Watteel, G. (1996). Early onset (
142. Gupta, M.A., Gupta, A.K., & Watteel, G.N. (1997). Stress and alopecia areata: a psychodermato- logic study. Acta Dermato-Venereologica (Stockholm), 77, 296–298.
143. Gupta, M.A., Gupta, A.K., & Watteel, G.N. (1998). Perceived deprivation of social touch in psoriasis is associated with greater psychological morbidity: an index of the stigma experience in dermatologic disorders. Cutis, 61, 339–342.
144. Gupta, M.A., Johnson, A.M., & Gupta, A.K. (1998). The development of an acne quality of life scale: reliability, validity, and relation to subjective acne severity in mild to moderated acne vulgaris. Acta Dermato-Venereologica, 78(6), 451–456.
145. Gupta, M.A., Gupta, A.K., Chandarana, P.C., & Johnson, A.M. (2000). Dissociative symptoms and self-induced dermatoses: a preliminary empirical study (Abstract). Psychosomatic Medicine, 62, 116.
146. Hashiro, M., & Okumura, M. (1998). The relationship between the psychological and immunological in patients with atopic dermatitis. Journal of Dermatological Science, 16(3), 231–235.
147. Hatch, M.L., Paradis, C., Friedman, S., Popkin, M., & Shalita, A.R. (1992). Obsessive-compulsive disorder in patients with chronic pruritic conditions: case studies and discussion. Journal of American Academy of Dermatology, 26, 549–551.
148. Hull, P.R., & D’Arcy, C. (2003). Isotretinoin use and subsequent depression and suicide: presenting the evidence. American Journal of Clinical Dermatology, 4,493–505.
149. Jick, S.S., Kremers, H.M., & Vasilakis-Scaramozza, C. (2000). Isotretinoin use and risk of depression, psychotic symptoms, suicide and attempted suicide. Archives of Dermatology, 136, 1231–1236.
150. Juhlin, L. (1981). Recurrent urticaria: clinical investigation of 330 patients. British Journal of Dermatology, 104, 369–381.
151. Kellett, S.C., & Gawkrodger, D.J. (1999). The psychological and emotional impact of acne and the effect of treatment with isotretinoin. British Journal of Dermatology, 140(2), 273–282.
152. Kent, G., & Keohane, S. (2001). Social anxiety and disfigurement: the moderating effects of fear of negative evaluation and past experiences. British Journal of Clinical Psychology, 40,23–34.
153. Kiebert, G., Sorensen, S.V., Revicki, D., Fagan, S.C., Doyle, J.J., Cohen, J., & Fivenson, D. (2002). Atopic dermatitis is associated with a decrement in health-related quality of life. International Journal of Dermatology, 41, 151–158.
154. Koblenzer, C.S., & Koblenzer, PJ. (1988). Chronic intractable atopic eczema. Archives of Dermatology, 124, 1673–1677.
155. Koo, J.Y.M., Shellow, W.V., Hallman, C.P., & Edwards, J.E. (1994). Alopecia areata and increased prevalence of psychiatric disorders. International Journal of Dermatology, 33, 849–850.
156. Lamberg, L. (1998). Acne drug depression warnings highlight need for expert care. Journal of American Medical Association, 279, 1057.
157. Mallon, E., Newton, J.N., Klassen, A., Stewart-Brown, S.L., Ryan, T.J., & Finlay, A.Y. (1999). The quality of life in acne: a comparison with general medical conditions using generic questionnaires. British Journal of Dermatology, 140(4), 672–676.
158. Monti, M., Sambvani, N., & Sacrini, F. (1998). Obsessive-compulsive disorders in dermatology. Journal of European Academy of Dermatology and Venereology, 11, 103–108.
159. Panconesi, P. (1984). Psychosomatic dermatology. Clinical Dermatology, 2, 94–179.
160. Picardi, A., Abeni, D., & Melchi, C.F. et al. (2000). Psychiatric morbidity in dermatological outpatients: an issue to be recognized. British Journal of Dermatology, 143, 983–991.
161. Picardi, A., Abeni, D., Renzi, C., Braga, M., Melchi, C.F., & Pasquini, P. (2003). Treatment outcome and incidence of psychiatric disorders in dermatologic out-patients. Journal of European Academy of Dermatology and Venereology, 17, 155–159.
162. Picardi, A., Amerio, P., Baliva, G., Barbieri, C., Teofoli, P., Bolli, S., Salvatori, V., Mazzotti, E., Pasquini, P., & Abeni, D. (2004). Recognition of depressive and anxiety disorders in dermatological outpatients. Acta Dermato-Venereologica, 84, 213–217.
163. Rees, L. (1957). An aetiological study of chronic urticaria and angioneurotic oedema. Journal of Psychosomatic Research, 2, 172–189.
164. Rubinow, D.R., Peck, G.L., Squillace, K.M., & Gantt, G.G. (1987). Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. Journal of American Academy of Dermatology, 17(1), 25–32.
165. Ruiz-Doblado, S., Carrizosa, A., & Garcia-Hernandez, M.J. (2003). Alopecia areata: psychiatric comorbidity and adjustment to illness. International Journal of Dermatology, 42, 434–437.
166. Russo, P.A., Ilchef, R., & Cooper, A.J. (2004). Psychiatric morbidity in psoriasis: a review. Australasian Journal of Dermatology, 45, 155–159.
167. Sadock, B.J., & Sadock, V.A. (2001). Kaplan and Sadock’s Pocket Book of Clinical Psychiatry, 3rd edn. Philadelphia: Lippincott Williams and Wilkins, pp. 261–274.
168. Sampogna, F., Picardi, A., Chren, M.M., Melchi, C.F., Pasquini, P., Masini, C., & Abeni, D. (2004). Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions. Psychosomatic Medicine, 66, 620–640.
169. Scheinman, P.L., Peck, G.L., Rubinow, D.R., DiGiovanni, J.J., Abangan, D.L., & Ravin, P.D. (1990). Acute depression from isotretinoin. Journal of American Academy of Dermatology, 22,1112–1114.
170. Sheehan-Dare, R.A., Henderson, M.J., & Cotterill, J.A. (1990). Anxiety and depression in patients with chronic urticaria and generalized pruritus. British Journal of Dermatology, 123, 769–774.
171. Shelley, W.B. (1981). Dermatitis artefacta induced in a patient by one of her multiple personalities. British Journal of Dermatology, 105, 587–589.
172. Stein, D.J., & Hollander, E. (1992). Dermatology and conditions related to obsessive-compulsive disorder. Journal of American Academy of Dermatology, 26,237–242.
173. Ullman, K.C., Moore, R.W., & Reidy, M. (1977). Atopic eczema: a clinical psychiatric study. Journal of Asthma Research, 14, 91–99.
174. Uzun, O., Basoglu, C., Akar, A., Cansever, A., Ozsahin, A., Cetin, M., & Ebrinc S. (2003). Body dysmorphic disorder in patients with acne. Comprehensive Psychiatry, 44, 415–419.
175. Woodruff, P.W.R., Higgins, E.M., Du Vivier, A.W.P., & Wessely, S. (1997). Psychiatric illness in patients referred to a dermatology-psychiatry clinic. General Hospital Psychiatry, 19,29–35.
176. Yazici, K., Baz, K., Yazici, A.E., Kokturk, A., Tot, S., Demirseren, D., & Buturak, V. (2004). Disease- specific quality of life is associated with anxiety and depression in patients with acne. Journal of European Academy of Dermatology and Venereology, 18, 435–439.
177. Zachariae, R., Zachariae, C., Ibsen, H.H., Mortensen, J.T., & Wulf, H.C. (2004). Psychological symptoms and quality of life of dermatology outpatients and hospitalized dermatology patients. Acta Dermato-Venereologica, 84, 205–212.
178. Albrecht, G.L., Walker, V., & Levy, J. (1982). Social distance from the stigmatized. A test of two theories. Social Science and Medicine,16, 1319–1327.
179. Bandura, A. (1977). Social Learning Theory, Englewood Cliffs, NJ: Prentice-Hall.
180. Baumeister, R., & Tice, D. (1990). Anxiety and social exclusion. Journal of Social and Clinical Psychology,9, 165–195.
181. Baumeister, R.F., Twenge, J.M., & Nuss, C.K. (2002). Effects of social exclusion on cognitive processes: anticipated aloneness reduces intelligent thought. Journal of Personality and Social Psychology,83, 817–827.
182. Boguslawska, R., Romanowski, C., Wilkinson, I., Montaldo, D., Singh, K., & Walecki, J. (1999). Introduction to functional magnetic resonance imaging. Medical Science Monitor,5,1179–1186.
183. Cline, T., Proto, A., Raval, P., & Di Paolo, T. (1998). The effects of brief exposure and of classroom teaching on attitudes children express towards facial disfigurement in peers. Educational Research,40, 55–68.
184. Crandall, C., & Moriarty, D. (1995). Physical illness, stigma and social rejection. Journal of Social Psychology, 34, 67–83.
185. Dion, K.K., Berscheid, E., & Walster, E. (1972). What is beautiful is good. Journal of Personality and Social Psychology,24,285–290.
186. Eagly, A., Ashmore, R., Makhijani, M., & Longo, L. (1991). What is beautiful is good, but… A meta-analytic review of research on the physical attractiveness stereotype. Psychological Bulletin,110, 109–128.
187. Finlay, A., & Khan, G. (1994). Dermatology life quality index (DLQI): a simple practical measure for routine clinical use. Clinical and Experimental Dermatology,19,210–216.
188. Frances, J. (2004). Educating Children with Facial Disfigurement: Creating Inclusive School Communities. London: Routledge Falmer.
189. Gilbert, P. (2000). What is shame? In: P. Gilbert, & B. Andrews (Eds), Shame: Interpersonal Behaviour, Psychopathology and Culture (pp. 3–37). New York: Oxford University Press.Stigmatisation and skin conditions
190. Ginsburg, I., & Link, B. (1989). Feelings of stigmatization in patients with psoriasis. Journal of the American Academy of Dermatology, 20, 53–63.
191. Goffman, E. (1968). Stigma. London: Penguin.
192. Gupta, M., Gupta, A., & Watteel, G. (1998). Perceived deprivation of social touch in psoriasis is associated with greater psychological morbidity: an index of the stigma experience in derma- tologic disorders. Cutis,61, 339–342.
193. Hagerty, B.M.K., & Patusky, K. (1995). Developing a measure of sense of belonging. Nursing Research,44, 9–13.
194. Hagerty, B.M., & Williams, R.A. (1999). The effects of sense of belonging, social support, conflict, and loneliness on depression. Nursing Research,48, 215–219.
195. Hagerty, B.M., Williams, R.A., Coyne, J.C., & Early, M.R. (1996). Sense of belonging and indicators of social and psychological functioning. Archives of Psychiatric Nursing,10,235–244.
196. Heason, S.L. (2003). The Development of a Model of Disfigurement: The Process of Living with Vitiligo. Sheffield: Unpublished PhD Thesis, University of Sheffield.
197. Heatherton, T.F., Kleck, R.E., Hebl, M.R. & Hull, J.G. (2000). The Social Psychology of Stigma. New York: Guildford.
198. Houston, B., & Bull, R. (1994). Do people avoid sitting next to someone who is facially disfigured? European Journal of Social Psychology,24,279–284.
199. Jacoby, A. (1994). Felt versus enacted stigma: a concept revisited. Social Science and Medicine,38, 269–274.
200. Jones, E., Farina, A., Hastorf, A., Markus, H., Miller, D., & Scott, R. (1984). Social Stigma. The Psychology of Marked Relationships. New York: Freeman.
201. Kellett, S., & Gawkrodger, D. (1999). The psychological and emotional impact of acne and the effect of treatment with isotretinoin. British Journal of Dermatology,140, 273–282.
202. Kent, G. (1999). Correlates of perceived stigma in vitiligo. Psychology & Health,14, 241–252.
203. Kent, G. (2002). Testing a model of disfigurement: effects of a skin camouflage service on wellbeing and appearance anxiety. Psychology & Health,17, 377–386.
204. Kent, G., & Keohane, S. (2001). Social anxiety and disfigurement: the moderating effects of fear of negative evaluation and past experience. British Journal of Clinical Psychology,40,23–34.
205. Kleck, R., & Strenta, A. (1980). Perceptions of the impact of negatively valued physical characteristics on social interaction. Journal of Personality and Social Psychology,39, 861–873.
206. Kurwa, H., & Finlay, A. (1995). Dermatology in-patient management greatly improves quality of life. British Journal of Dermatology, 133, 575–578.
207. Kurzban, R., & Leary, M. (2001). Evolutionary origins of stigmatization: the functions of social exclusion. Psychological Bulletin,127, 187–208.
208. Langer, E., Fiske, S., Taylor, S., & Chanowitz, B. (1976). Stigma, staring, and discomfort: a novel- stimulus hypothesis. Journal of Experimental and Social Psychology,12, 451–463.
209. Leary, M. (1990). Responses to social exclusion: social anxiety, jealousy, loneliness, depression, and low self-esteem. Journal of Social and Clinical Psychology,9,221–229.
210. Lee, R.M., & Robbins, S.B. (1995). Measuring belongingness - the social connectedness and the social assurance scales. Journal of Counseling Psychology,42,232–241.
211. Lee, R.M., & Robbins, S.B. (1998). The relationship between social connectedness and anxiety, self-esteem, and social identity. Journal of Counseling Psychology,45, 338–345.
212. Lerner, M., & Miller, D. (1978). Just world research and the attribution process: looking back and ahead. Psychological Bulletin, 85, 1030–1051.
213. Martini, T., & Page, S. (1998). Attributions and the stigma of illiteracy: understanding help seeking in low literate adults. Canadian Journal of Behavioural Science,28, 121–129.
214. Papadopoulous, L., Bor, R., & Legg, C. (1999). Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive behavioural therapy. British Journal of Medical Psychology,10, 11–12.
215. Rapp, S., Feldman, S., Exum, M., Fleischer, A., & Reboussin, D. (1999). Psoriasis causes as much disability as other major medical diseases. Journal of the American Academy of Dermatology, 41,401–407.
216. Robinson, E., Rumsey, N., & Partidge, J. (1996). An evaluation of the impact of social interaction skills training for facially disfigured people. British Journal of Plastic Surgery,49, 281–289.
217. Rozin, P., & Fallon, A. (1987). A perspective on disgust. Psychological Review,94,23–41.
218. Rumsey, N., Bull, R., & Gahagan, D. (1982). The effect of facial disfigurement on the proxemic behaviour of the general public. Journal of Applied Social Psychology,12, 137–150.
219. Sarwer, D., Wadden, T., Pertchuk, M., & Whitaker, L. (1998). The psychology of cosmetic surgery: a review and reconceptualization. Clinical Psychology Review,18, 1–22.
220. Schmid-Ott, G., Jaeger, B., Kuensebeck, H., Ott, R., & Lamprecht, F. (1996). Dimensions of stigmatisation in patients with psoriasis in a questionnaire on experience with skin complaints. Dermatology,193, 304–310.
221. Smart, L., & Wegner, D. (1999). Covering up what can’t be seen: concealable stigma and mental control. Journal of Personality and Social Psychology,77,474–486.
222. Sommer, K.L., & Baumeister, R.F. (2002). Self-evaluation, persistence, and performance following implicit rejection: the role of trait self-esteem. Personality and Social Psychology Bulletin, 28, 926–938.
223. Thompson, A., & Kent, G. (2001). Adjusting to disfigurement: processes involved in dealing with being visibly different. Clinical Psychology Review,21, 663–682.
224. Troilius, A., Wrangsjo, B., & Ljunggren, B. (1998). Potential psychological benefits from early treatment of port-wine stains in children. British Journal of Dermatology,139, 59–65.
225. Twenge, J.M., Catanese, K.R., & Baumeister, R.F. (2003). Social exclusion and the deconstructed state: time perception, meaninglessness, lethargy, lack of emotion, and self-awareness. Journal of Personality and Social Psychology,85,409–423.
226. Vardy, D., Besser, A., Amir, M., Gesthalter, B., Biton, A., & Buskila, D. (2002). Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients. British Journal of Dermatology,147, 736–742.
227. Wahl, A.K., Gjengedal, E., & Hanestad, B.R. (2002). The bodily suffering of living with severe psoriasis: in depth interviews with 22 hospitalised patients with psoriasis. Qualitative Health Research,12,250–261.
228. Weiner, B., Perry, R., & Magnusson, J. (1988). An attributional analysis of reactions to stigmas. Journal of Personality and Social Psychology,55, 738–748.
229. Alderman, C. (1989). Not just skin deep. Nursing Standard, 37,22–24.
230. Allegranti, I., Gon, T., Magaton-Rizzi, G., & Aguglia, E. (1994). Prevalence of alexithymia characteristics in psoriatic patients. Acta Dermatologica Vererologica, 186, 146–147.
231. All Party Parliamentary Group on Skin (2003). Report on the enquiry into the impact of skin diseases on people’s lives. London: HMSO.
232. Altabe, M., & Thompson, J.K., (1996). Body image: a cognitive self-schema construct. Cognitive Therapy and Research, 20, 171–193.
233. Benrud-Larson, L.M., Heinberg, L.J., Boling, C., Reed, J., White, B., Wigley, F.M., & Haythornwaite, J.A. (2003). Body image dissatisfaction among women with scleroderma: extent and relationship to psychosocial function. Health Psychology, 22, 130–139.
234. Ben-Tovim, D., & Walker, M.K. (1995). Body image, disfigurement and disability. Journal of Psychosomatic Research, 39,283–291.
235. Beuf, A. (1990). Beauty is the Beast. Philadelphia: University of Pennsylvania Press.
236. Bull, R., & Stevens, J. (1981). The effects of facial disfigurement on helping behaviour. The Italian Journal of Psychology, 8, 25–31.
237. Cash, T.F., & Labarge, A.S. (1996). Development of the appearance schemas inventory: a new cognitive body-image assessment. Cognitive Therapy and Research, 20, 37–50.
238. Cotterill, J.A., & Cunliffe, W.J. (1997). Suicide in dermatology patients. British Journal of Dermatology, 137, 246–250.
239. Clark, S.M., Goulden, V., Finlay, A.Y., & Cunliffe, W.J. (1997). The psychological and social impact of acne: a comparison study using 3 acne disability questionnaires. British Journal of Dermatology Supplement, 137, 41–42.
240. Cobb, S. (1976). Social support as a moderator of life stress. Psychosomatic Medicine, 38, 300–314.
241. Dion, K.K., Berscheid, E., & Walster, E. (1972). What is beautiful is good. Journal of Personality and Social Psychology, 11, 1–18.
242. Finlay, A.Y., Khan, G.K., Luscombe, D.K., & Salek, M.S. (1990). Validation of sickness impact profile and psoriasis disability index in psoriasis. British Journal of Dermatology, 123,751–756.
243. Fortune, D.G., Main, C.J., O’Sullivan, T.M., & Griffiths, C.E.M. (1997). Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress. British Journal of Dermatology, 137, 755–760.
244. Fortune, D.G., Richards, H.L., Griffiths, E.M., & Main, C. (2002). Psychological stress, distress and disability in patients with psoriasis: consensus and variation in the contribution of illness perceptions, coping and alexithymia. British Journal of Clinical Psychology, 41, 157–174.
245. Fortune, D.G., Richards, H.L., Griffiths, C.E.M., & Main, C.J. (2004). Targeting cognitive- behaviour therapy to patients’ implicit model of psoriasis: results from a patient preference controlled trial. British Journal of Clinical Psychology, 43, 65–82.
246. Gawkrodger, D. (1989). Manic depression induced by dapsone in patient with dermatitis- herpetiformis. British Medical Journal, 299(6703), 860.
247. Gawkrodger, D.J. (2002). Dermatology: An Illustrated Colour Text, 3rd edn. Edinburgh: Churchill Livingstone.
248. Gilbert, P., & Miles, J. (2002). Body Shame: Conceptualization, Research and Treatment. Hove: Bruner-Routledge.
249. Grandfield, T., Thompson, A., & Turpin, G. (2004). An attitudinal study of responses to dermatitis using the implicit association test. Poster presented at the Annual British Psychological Society Conference, April.
250. Harlow, D., Poyner, T., Finlay, A.Y., & Dykes, PJ. (2000). Impaired quality of life of adults with skin disease in primary care. British Journal of Dermatology, 143, 979–982.
251. Hill, L., & Kennedy, P. (2002). The role of coping strategies in mediating subjective disability in people who have psoriasis. Psychology, Health and Medicine, 7, 261–269.
252. Higgins, E. (1987). Self-discrepancy: a theory relating to self and affect. Psychological Review, 94, 319–340.
253. Hughes, J., Barraclough, B., Hamblin, L., & White, J. (1983). Psychiatric symptoms in dermatology patients. British Journal of Psychiatry, 143, 51–54.
254. Humphreys, S., & Humphreys, R. (1998). Psychiatric morbidity and skin disease: what dermatologists think they see. British Journal of Dermatology, 139, 679–681.
255. Jobling, R. (1976). Psoriasis: a preliminary questionnaire study of sufferers’ subjective experience. Clinical and Experimental Dermatology, 1, 233.
256. Jowett, S., & Ryan, T. (1985). Skin disease and handicap: an analysis of the impact of skin conditions. Social Science and Medicine, 20, 424–429.
257. Kalick, S., Goldwyn, R., & Noe, J. (1981). Social issues and body image concerns of port wine stain patients undergoing laser therapy. Lasers in Surgery and Medicine, 1,205–213.
258. Kauhanen, J., Kaplan, G.A., Julkunen, J., & Salonen, J.T. (1994). The association of alexithymia with all cause mortality: prospective epidemiologic evidence. Psychosomatic Medicine, 56, 149.
259. Kellett, S.C., & Gawkroger, D.J. (1999). The psychological and emotional impact of acne and the effect of treatment with isotretinoin. British Journal of Dermatology, 140,273–282.
260. Kellett, S., & Gilbert, P. (2001). Acne: a biopsychosocial and evolutionary perspective with a focus on shame. British Journal of Health Psychology, 6, 1–24.
261. Kent, G. (2002). Testing a model of disfigurement: effects of a skin camouflage service on well being and appearance anxiety. Psychology and Health, 17, 377–386.
262. Kent, G., & Keohane, S. (2001). Social anxiety and disfigurement: the moderating effects of fear of negative evaluation and past experience. British Journal of Clinical Psychology, 40, 339–342.
263. Kent, G., & Thompson, A. (2002). The development and maintenance of shame in disfigurement. In: P. Gilbert & L. Miles (Eds), Body Shame: Conceptualisation, Research and Treatment, New York: Brunner-Routledge.
264. Kerr, R.L., Bull, R.H.C., MacCoun, R.J., & Rathborn, H. (1985). Judgements of victim attractiveness, care and disfigurement on the judgements of American and British mock jurors. Journal of Social Psychology, 24,47–58.
265. Langlois, J., & Sawin, D. (1981). Infant physical attractiveness as an elicitor of differential parenting behaviours. Paper presented at the Society for Research in Child Development, Boston.
266. Walters, E. (1997). Problems faced by children and families living with visible differences. In: R. Lansdown, N. Rumsey, E. Bradbury, T. Carr, & J. Partridge (Eds), Visibly Different: Coping with Disfigurement. Oxford: Butterworth-Heinemann.
267. Lanigan, S., & Cotterill, J. (1989). Psychological disabilities amongst patients with port wine stains. British Journal of Dermatology, 121, 209–215.
268. Lazurus, R., & Folkman, S. (1984). Stress, Appraisal and Coping. New York: Springer.
269. Leary, M. (1983). A brief version of the fear of negative evaluation scale. Personality and Social Psychology Bulletin, 9, 371–376.
270. Leary, M., Rapp, S., Herbst, K., Exum, M., & Feldman, S. (1998). Interpersonal concerns and psychological difficulties of psoriasis patients: effects of disease severity and fear of negative evaluation. Health Psychology, 17, 1–7.
271. Leventhal, H., Diefenbach, M., & Leventhal, E. (1992). Illness cognition: using common sense to understand treatment adherence and affect cognition interactions. Cognitive Therapy and Research, 16, 143–163.
272. Leventhal, H., Meyer, D., & Nerenz, D. (1980). The common sense representation of illness danger. In: S. Rachman (Ed.), Contributions to Medical Psychology (Vol. 2.), New York: Pergamon Press, pp. 7–30.
273. Miles, J. (2002). Psoriasis: The role of shame on quality of life. In: P. Gilbert, & J. Miles (Eds), Body Shame: Conceptualisation, Research and Treatment. New York: Brunner-Routledge.
274. Moos, R., & Schaefer, J. (1984). The crisis of physical illness: an overview and conceptual approach. In: R. Moos (Ed.), Coping with Physical Illness: New Perspectives, New York: Plenum, pp. 3–25.
275. Ng, C.H., & Schweitzer, I. (2003). The association between depression and isotretinoin use in acne. Australian and New Zealand Journal Of Psychiatry, 37, 78–84.
276. Papadopoulos, L., Bor, R., & Legg, C. (1999a). Psychological factors in cutaneous disease: an overview of research. Psychology, Health and Medicine, 4, 107–126.
277. Papadopoulos, L., Bor, R., & Legg, C. (1999b). Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive-behavioural therapy. British Journal of Medical Psychology, 72, 385–396.
278. Partridge, J. (1996). Facial Disfigurement. The Full Picture. London: Changing Faces.
279. Picardi, A., Abeni, D., Renzi, C., Braga, M., Puddu, P., & Pasquini, P. (2001). Increased psychiatric morbidity in female outpatients with skin lesions on visible parts of the body. Acta Dermato- Venereologica, 81,410–414.
280. Picardi, A., Abeni, D., Renzi, C., Braga, M., Melchi, C.F., & Pasquini, P. (2003a). Treatment outcome and incidence of psychiatric disorders in dermatological outpatients. Journal of the European Academy of Dermatology and Venereology, 17, 155–159.
281. Picardi, A., Pasquini, P., Cattaruzza, M.S., Gaetano, P., Melchi, C.F., Baliva, G., Camaioni, D., Tiago, A., Abeni, D., & Biondi, M. (2003b). Stressful life events, social support, attachment security and alexithymia in vitiligo. Psychotherapy and Psychosomatics, 73, 150–158.
282. Picardi, A., Pasquini, P., Cattaruzza, M.S., Gaetano, P., Baliva, G., Melchi, C.F., Tiago, A., Camaioni, D., Abeni, D., & Biondi, M. (2003c). Only limited support for a role of psychosomatic factors in psoriasis: results from a case-control study. Journal of Psychosomatic Research, 55, 189–196.
283. Picardi, A., Pasquini, P., Cattaruzza, M.S., Gaetano, P., Baliva, G., Melchi, C.F., Papi, M., Camaioni, D., Tiago, A., Gobello, T., & Biondi, M. (2003d). Psychosomatic factors in first onset alopecia areata. Psychosomatics, 44, 374–380.
284. Porter, J.R., & Beuf, A.H. (1988). Response of older people to impaired appearance: the effect of age on disturbance by vitiligo. Journal of Aging Studies, 2, 167–181.
285. Porter, J.R., Beuf, A.H., Lerner, A., & Nordlund, J. (1986). Psychosocial effects of vitiligo. A comparison with ‘normal’ control subjects with psoriasis patients, and with patients with other pigmentary disorders. Journal of the American Academy of Dermatology, 15,220–224.
286. Rapp, S.R., Cottrell, C.A., & Leary, M.R. (2001). Social coping strategies associated with quality of life decrements among psoriasis patients. British Journal of Dermatology, 145, 610–616.
287. Richardson, J. (1997). Chapter 10. In: R. Lansdown, N. Rumsey, E. Bradbury, T. Carr, & J. Partridge (Eds), Visibly Different: Coping with Disfigurement. Oxford: ButterworthHeinemann.
288. Robinson, E., Rumsey, N., & Partridge, J. (1996). An evaluation of the impact of social interaction skills training for facially disfigured people. British Journal of Plastic Surgery, 49,281–289.
289. Root, S., Kent, G., & Al-Abadie, M.S.K. (1994). The relationship between disease severity, disability and psychological distress in patients undergoing PUVA treatment for psoriasis. Dermatology, 189,234–237.
290. Rumsey, N., Bull, R., & Gahagan, D. (1982). The effect of facial disfigurement on the proxemic behaviour of the general public. Journal of Applied Social Psychology, 12, 137–150.
291. Rumsey, N., & Harcourt, D. (2004). Body image and disfigurement: issues and interventions. Body Image, 1, 83–97.
292. Salzer, B., & Schallreuter, K. (1995). Investigation of personality structure in patients with vitiligo and a possible association with catecholamine metabolism. Dermatology, 190, 109–115.
293. Samerotte, G.C., & Harris, M.B. (1976). The effects of actual and attempted theft, need, and a previous favor on altruism. Journal of Social Psychology, 99, 193–202.
294. Shaw, W. (1981). Folklore surrounding facial deformity and the origins of facial prejudice. British Journal of Plastic Surgery, 34,237–246.
295. Scharloo, M., Kaptein, A.A., Weinman, J., Bergman, W., Vermeer, B.J., & Rooijmans, H.G.M. (2000). Patients’ illness perceptions as predictors of functional status in psoriasis: a 1-year follow-up. British Journal of Dermatology, 142, 899–907.
296. Tangey, J., & Fischer, K. (1995). Self-Conscious Emotions. The Psychology of Shame, Guilt, Embarrassment and Pride. New York: Guildford Press.
297. Thompson, A. (1998). Exploring the Process of Adjustment to Disfigurement with Particular Reference to Vitiligo. Unpublished doctoral thesis. University of Sheffield, UK.
298. Thompson, A., & Kent, G. (2001). Adjusting to disfigurement: processes involved in dealing with being visibly different. Clinical Psychology Review, 21, 663–682.
299. Thompson, A.R., Kent, G., & Smith J.A. (2002). Living with vitiligo: dealing with difference. British Journal of Health Psychology, 7, 213–225.
300. Van der Donk, J., Hunfield, J., Passcher, J., Knegt-Junk, K., & Nieber, C. (1994). Quality of life and maladjustment associated with hair loss in women with alopecia androgenetica. Social Science and Medicine, 38, 159–163.
301. Wahl, A.K., Gjengedal, E., & Hanestad, B.R. (2002). The bodily suffering of living with severe psoriasis: in depth interviews with 22 hospitalised patients with psoriasis. Qualitative Health Research, 12,250–261.
302. Walters, E. (1997). Problems faced by children and families living with visible differences. In: R. Lansdown, N. Rumsey, E. Bradbury, T. Carr, & J. Partridge (Eds), Visibly Different: Coping with Disfigurement. Oxford: Butterworth-Heinemann.
303. Zhu, Y.I., & Stiller, M.J. (2001). Dapsone and sulfones in dermatology: overview and update. Journal of the American Academy of Dermatology, 45,420–434.
304. Ainsworth, M.D.S., Blehar, M.C., Waters, E. & Wall, S. (1978). Patterns of Attachment: A Study of the Strange Situation. Hillsdale, NJ: Lawrence Erlbaum.
305. Altschuler, J. (1997). Gender and illness: implications for family therapy. Journal of Family Therapy, 15, 381–401.
306. Baldwin, M.W. & Fehr, B. (1995). On the instability of attachment style ratings. Personal Relationships, 2, 247–261.
307. Bolger, N., Foster, M., Vinokur, A.D., & Ng, R. (1996). Close relationships and adjustment to a life crisis: the case of breast cancer. Journal of Personality and Social Psychology, 70, 283–294.
308. Bowlby, J. (1969–1980). Attachment and loss. London: Hogarth Press, pp. 129.
309. Blackney, P., Herndon, D., Desai, M., Beard, S., & Wales-Seale, P. (1988). Long-term psychological adjustment of children after severe burn injury. Journal of Burn Care and Rehabilitation, 11, 472–475.
310. Bradbury, E. (1996). Counselling People with Disfigurement. Leicester: BPS Books.
311. Buckwalter, K. (1982). The influence of skin disorders on sexual expression. Sex Disability, 5, 98–106.
312. Burman, B., & Mangolin, G. (1992). Analysis of the association between marital relationship and health problems: an interactional perspective. Psychological Bulletin, 112, 39–63.
313. Campbell, D.B. (2003). The relationships among negative self-schemas, partner attachment styles, and relationship adjustment. Dissertation Abstracts International: Section B: The Science and Engineering, 64(2B), 1001.
314. Collins, N.L., & Read, S.J. (1990). Adult attachment, working models, and relationship quality in dating couples. Journal of Personality and Social Psychology, 58, 644–663.
315. Collins, N.L., & Read, S.J. (1994). Cognitive representations of attachment: the structure and function of working models. In: K. Bartholomew, & D. Perlman (Eds), Advances in personal relationships. London: Jessica Kingsley, pp. 53–90.
316. Coyne, J.C., & Smith, D.A.F. (1991). Couples coping with myocardial infarction: I. a contextual perspective on wives’ distress. Journal of Personality and Social Psychology, 6, 404–412.
317. Coyne, J.C., Ellard, J.H., & Smith, D.A. (1990). Social support, interdependence, and the dilemmas of helping. In: B.R. Sarason, I.G. Sarason, & G.R. Pierce (Eds), Social Support: An Interactional View. New York: John Wiley, pp. 129–149.
318. Crowell, J., Fraley, R.C., & Shaver, P.R. (1999). Measures of individual differences in adolescent and adult attachment. In: J. Cassidy, & P.R. Shaver (Eds), Handbook of Attachment: Theory, Research, and Clinical Applications. New York: Guilford Press, pp. 434–465.
319. Cutrona, C.E. (1996). Social support as a determinant of marital quality: The interplay of negative and supportive behaviors. In: G.R. Pierce, B.R. Sarason, & I.G. Sarason (Eds), Handbook of Social Support and the Family. New York: Plenum, pp. 173–194.
320. Danoff-Burg, S., & Revenson, T.A. (2000). In: K.B. Schmaling, & T.G Sher (Eds), The Psychology of Couples and Illness. Washington: American Psychological Association, pp. 105–133.
321. De Longis, A., & O’Brien, T. (1990). An interpersonal framework for stress and coping: an application to the families of alzheimers patients. In: M.A.P. Stephens, S.E. Hobfoll, D.L. Tennebaum, & J.H. Crowther (Eds), Stress and Coping in Later Life Families. Washington: Hemisphere, pp. 221–239.
322. Feeney, J.A., & Noller, P. (1990). Attachment style as a predictor of adult romantic relationships. Journal of Personality and Social Psychology, 58, 281–291.
323. Feeney, J.A., & Noller, P. (1996). Adult Attachment. London: Sage.
324. Finlay, A.Y., & Coles, E.C. (1995). The effect of severe psoriasis on the quality of life of 369 patients. British Journal of Dermatology, 132,236–244.
325. Fuller, T.L., & Fincham, F.D. (1995). Attachment style in married couples: relation to current marital functioning, stability over time, and method of assessment. Personal Relationships, 2, 17–34.
326. Ginsburg, I.H. (1996). The psychosocial impact of skin disease: an overview. Psychodermatology, 14(3), 473–484.
327. Glick, I.O., Weiss, R.S., & Parkes, C.M. (1974). The First Years of Bereavement. New York: John Wiley.
328. Goleman, D. (1995). Emotional Intelligence. London: Bloomsbury.
329. Gottlieb, B.H., & Wagner, F. (1991). Stress and support processes in close relationships. In: J. Eckenrode (Ed.), The Social Context of Coping. New York: Plenum, pp. 165–188.
330. Gupta, M.A., & Gupta, A.K. (1997). Psoriasis and sex: a study of moderately to severely affected patients. International Journal of Dermatology, 36, 359–362.
331. Gupta, M., Schork, N., & Gupta, A. (1993). Suicidal ideation in psoriasis. International Journal of Dermatology, 32, 188–190.
332. Hazan, C., & Shaver, P.R. (1987). Romantic love conceptualised as an attachment process. Journal of Personality and Social Psychology, 52, 511–524.
333. Heller, K., & Rook, K.S. (1997). Distinguishing the theoretive functions of social ties. In: S. Duck (Ed.), Handbook of Personal Relationships, 2nd edn. Chichester, England: Wiley, pp. 648–670.
334. Hughes, J., Barraclough, B., Hamblin, L., & White, J. (1983). Psychiatric symptoms in dermatology patients. British Journal of Psychiatry, 143, 51–54.
335. Hunter, J.A.A., Savin, J.A., & Dahl, M.V. (1989). Clinical Dermatology. London: Blackwell Scientific Publishing.
336. James, P. (1989). Dermatology. In: A.K. Broome (Ed.), Health Psychology. London: Chapman and Hall, pp. 183–207.
337. Jobling, R.G. (1976). Psoriasis: a preliminary questionnaire study of sufferer’s subjective experience. Clinical Experimental Dermatology, 1, 233–236.
338. Jowett, S., & Ryan, T. (1985). Skin disease and handicap: An analysis of the impact of skin conditions. Social Science and Medicine, 20(4), 425–429.
339. Kapp-Simon, K., & McGuire, D. (1997). Observed social interaction patterns in adolescents with and without craniofacial conditions. Cleft Palate-Craniofacial Journal, 34, 380–384.
340. Kellet, S. (2002). Shame-focused acne: a biopsychosocial conceptualisation and treatment rationale. In: P. Gilbert, & J. Miles (Eds), Body Shame: Conceptualisation, Research and Treatment. East Sussex: Brunner-Routledge, pp. 135–154.
341. Kent, G. (2000). Understanding the experiences of people with disfigurements: an integration of four models of social and psychological functioning. Psychology, Health and Medicine, 5(2), 117–129.
342. Kent, G., & Thompson, A. (2002). The development and maintenance of shame in disfigurement: implications for treatment. In: P. Gilbert, & J. Miles (Eds), Body Shame. Hove: Brunner- Routledge, pp. 103–116.
343. Koblenzer, C.S. (1987). Psychocutaneous Disease. Orlando: Grune & Stratton.
344. Koo, J. (1996). Population based epidemiologic study of psoriasis with emphasis on quality of life assessment. Psychodermatology, 14(3), 485–496.
345. Landsdown, R.L., Rumsey, N., Bradbury, E., Carr, T., & Partridge, J. (1997). Visibly Different: Coping with Disfigurement. Oxford: Butterworth-Heinemann.
346. Lannigan, S., & Coterill, J. (1989). Psychological disabilities amongst patients with port wine stains. British Journal of Dermatology, 121, 209–215.
347. Lawrence, E., Eldridge, K.A., & Christensen, A. (1998). The enhancement of traditional behavioural couples therapy: consideration of individual factors and dyadic development. Clinical Psychology Review, 18(6), 745–764.
348. Leary, M., & Kowalski, R. (1995). Social Anxiety. London: Guildford Press.
349. Locker, D. (1983). Disability and Disadvantage: The Consequences of Chronic Illness. London: Tavistock.
350. Love, B., Byrne, C., Roberts, J., Browne, G., & Brown, B. (1987). Adult psychosocial adjustment following childhood injury: the effect of disfigurement. Journal of Burn Care and Rehabilitation, 8, 280–285.
351. Lyons, R.F., & Meade, D. (1995b). Painting a new face on relationships: relationship remodelling in response to chronic illness. In: S. Duck, & J.T. Wood (Eds), Confronting Relationship Challenges. London: Sage, pp. 181–210.
352. Lyons, R., & Sullivan, M. (1998). Curbing loss in illness and disability: a relationship perspective. In: J.H. Harvey (Ed.), Perspectives on Personal and Interpersonal Loss: A Sourcebook. Bristol: Taylor & Francis, pp. 137–152.
353. Lyons, R.F., Sullivan, M.J.L., Ritvo, P.G., & Coyne, J.C. (1995a). Relationships in Chronic Illness and Disability. Thousand Oaks, California: Sage.
354. Main, M., Kaplan, N., & Cassidy, J. (1985). Security in infancy, childhood and adulthood: a move to the level of representation. Monographs of the Society for Research in Child Development, 50(1–2), 66–104.
355. Medansky, R. (1986). Psoriasis and sexuality. Medical Aspects of Human Sexuality, 20, 144–149.
356. Meli, C., & Giorgini, S. (1984). Aesthetics in psychosomatic dermatology: 1. Cosmetics, self image and attractiveness. Clinics in Dermatology, 2(4), 180–187.
357. Meyerowits, B.E., Levin, K., & Harvey, J.H. (1997). On the nature of cancer patient’s social interactions. Journal of Personal and Interpersonal Loss, 2, 49–69.
358. Mikulincer, M., & Nachshon, O. (1991). Attachment styles and patterns of self-disclosure. Journal of Personality and Social Psychology, 61, 321–331.
359. Miles, J. (2002). Psoriasis: the role of shame on quality of life. In: P. Gilbert, & J. Miles (Eds), Body Shame: Conceptualisation, Research and Treatment. Hove: Brunner- Routledge, pp. 119–134.
360. Monsour, M. (1992). Meanings of intimacy in cross and same-sex friendships. Journal of Social and Personal Relationships, 9, 277–295.
361. Morgan, M., Patrick, D.L., & Charlton, J.R. (1984). Social networks and psychosocial support among disabled people. Social Science and Medicine, 19, 489–497.
362. Papadopoulos, L., & Walker, C. (2003). Understanding Skin Problems. London: John Wiley & Sons.
363. Pistrang, N., Barker, C., & Rutter, C. (1997). Social support as conversation: analysing breast cancer patient’s interactions with their partners. Social Science and Medicine, 45(5), 773–782.
364. Porter, J.R., Beuf, A.H., Lerner, A., & Nordlund, J. (1990). The effect of vitiligo on sexual relationships. Journal of the American Academy of Dermatology, 22,221–222.
365. Richards, H.L., Fortune, D.G., Chong, S.L.P., Manson, D.L., Sweeney, S.K.T., Main, C.J., & Griffiths, C.E.M. (2004). Divergent beliefs about psoriasis are associated with increased psychological distress. Journal of Investigative Dermatology, 123(1), 49–56.
366. Rodin, M.J. (1982). Non-engagement, failure to engage, and disengagement. In: S. Duck (Ed.), Personal Relationships. London: Academic Press, pp. 31–49.
367. Rolland, J.S. (1994). Families, Illness and Disability: An Integrative Treatment Model. New York: Basic Books.
368. Rumsey, N., & Harcourt, D. (2004). Body image and disfigurement. Body Image, 1, 83–97.
369. Schmaling, K.B., & Sher, T.G. (1997). Physical health and relationships. In: W.K. Halford, & H.J. Markman (Eds), Clinical Handbook of Marriage and Couples. New York: Wiley, pp. 323–345.
370. Schmaling, K.B., & Sher, T.G. (2000). The Psychology of Couples and Illness. Washington: American Psychological Association.
371. Shaver, P.R., & Hazan, C. (1988). A biased overview of the study of love. Journal of Personality and Social Psychology, 5,473–501.
372. Simpson, J.A. (1990). Influence of attachment styles on romantic relationships. Journal of Personality and Social Psychology, 59, 971–980.
373. Simpson, J.A., Rholes, W.S., & Nelligan, J.S. (1992). Support seeking and support giving within couples in an anxiety-provoking situation: The role of attachment styles. Journal of Personality and Social Psychology, 62,434–446.
374. Simpson, J.A., Rholes, W.S., & Alonso, D. (1996). The impact of conflict on close relationships: An attachment perspective. Journal of Personality and Social Psychology, 71, 899–914.
375. Skerrett, K. (1998). Couples adjustment to the experience of breast cancer. Family, Systems and Health, 16(3), 281–298.
376. Story, L.B., & Bradbury, T.N. (2004). Understanding marriage and stress: Essential questions and challenges. Clinical Psychology Review, 23, 1139–1162.
377. Tantleff-Dunn, S., & Gokee, J.L. (2002). Interpersonal influences on body image development. In: T.F. Cash, & T. Pruzinsky (Eds), Body Image: A Handbook of Theory, Research and Clinical Practice. London: Guildford Press, pp. 108–124.
378. Vaux, A. (1988). Social Support: Theory, Research, and Intervention. New York: Praeger.
379. Weiderman, M.W. (2002). Body image and sexual functioning. In: T.F. Cash, & T. Pruzinsky (Eds), Body Image: A Handbook of Theory, Research and Clinical Practice. London: Guildford Press, pp. 108–124.
380. Whiffen, V.E., & Gotlib, I.H. (1989). Stress and coping in maritally distressed and non-distressed couples. Journal of Social and Personal Relationships, 6, 327–344.
381. Absolon, C.M., Cottrell, D., Eldridge, S.M., & Glover M.T. (1997). Psychological disturbance in atopic eczema: the extent of the problem in school aged children. British Journal of Dermatology,137, 241–245.
382. Ainsworth, M.D.S., Blehar, M.C., Waters, E., & Wall, S. (1978). Patterns of Attachment. Hillsdale, NJ: Erlbaum.
383. Bick, E. (1986). Further considerations on the function of the skin in early object relations: findings from infant observations integrated into child and adult analysis. British Journal of Psychotherapy,2, 292–299.
384. Bowlby, J. (1980). Attachment and Loss: Vol. III Loss. New York: Basic Books.The impact of skin disease on children and their families
385. Bradbury, E. (1996). Counselling People with Disfigurement. Leicester: British Psychological Society.
386. Bridgett, C., Noren, P., & Staughton, R. (1996). Atopic Skin Disease: A manual for Practitioners. Basingstoke: Wrightson Biomedical Publishing.
387. Chuh, A.A.T. (2003). Quality of life in children with pityriasis rosea: a prospective case control study. Pediatric Dermatology,20, 474–478.
388. Clarke, A. (1999). Psychosocial aspects of facial disfigurement: problems, management and the role of a lay-led organisation. Psychology, Health and Medicine,4, 127–142.
389. Cork, M.J., Britton, J., Butler, L., Young, S., Murphy, R., & Keohane, S.G. (2003). Comparison of parent knowledge, therapy utilisation and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. British Journal of Dermatology, 149, 582–589.
390. Czyzewski, D.I., & Lopez, M. (1998). Clinical psychology in the management of pediatric skin disease. Dermatologic Clinics,16, 619–629.
391. Daud, L.R., Garralda, M.E., & David, T.J. (1993). Psychosocial adjustment in preschool children with atopic eczema. Archives ofDisease in Childhood, 69, 670–676.
392. Elliott, B.E., & Luker, K. (1997). The experiences of mothers caring for a child with severe atopic eczema. Journal ofClinical Nursing, 6, 241–247.
393. Ernst, E. (2000). The usage of complementary therapies by dermatological patients: a systematic review. British Journal of Dermatology,142, 857–861.
394. Fehnel, S.E., McLeod, L.D., Brandman, J., Arbit, D.I., McLaughlin-Miley, C.J., Coombs, J.H., Martin, A.R., & Girman, C.J. (2002). Responsiveness of the acne specific quality of life questionnaire (Acne-QoL) to treatment for acne vulgaris in placebo-controlled clinical trials. Quality of Life Research,11, 809–816.
395. Gil, K.M., Keefe, F.J., & Sampson, H.A. (1988). Direct observation of scratching behavior in children with atopic dermatitis. Behavior Therapy,19,213–227.
396. Holme, S.A., Man, I., Sharpe, J.L., Dykes, P.J., Lewis-Jones, M.S., & Finlay, A.Y. (2003). The children’s dermatology life quality index: validation of the cartoon version, British Journal of Dermatology,148, 285–290.
397. Horn, H.M., & Tidman, M.J. (2002). Quality of life in epidermolysis bullosa. Clinical and Experimental Dermatology,27, 707–710.
398. Howlett, S. (1999). Emotional dysfunction, child-family relationships and childhood atopic dermatitis. British Journal of Dermatology,140, 381–384.
399. Hull, P.R., & D’Arcy, C. (2003). Isotretinoin use and subsequent depression and suicide: presenting the evidence. American Journal of Clinical Dermatology,4, 493–505.
400. Kish, V., & Lansdown, R. (2000). Meeting the psychosocial impact of facial disfigurement. Clinical Child Psychology and Psychiatry,5, 497–512.
401. Koblenzer, C.S. (1990). A neglected but crucial aspect of skin function: a challenge for the 90s. International Journal of Dermatology,29, 185–186.
402. Lavigne, J.V., & Faier-Routman, J. (1992). Psychological adjustment to pediatric physical disorders: a meta-analytic review. Journal of Pediatric Psychology,17, 133–157.
403. Lawson, V., Lewis-Jones, M.S., Finlay, A.Y., Reid, P., & Owens, R.G. (1998). The family impact of childhood atopic dermatitis: the dermatitis family impact questionnaire. British Journal of Dermatology,138, 107–113.
404. Lazarus, R.S., & Folkman, S. (1984). Stress, Appraisal and Coping. New York: Springer.
405. Lewis-Jones, M.S., & Finlay, A.Y. (1995). The children’s dermatology life quality index (CDLQI): initial validation and practical use. British Journal of Dermatology,132, 942–949.
406. McHenry, P.M., Williams, H.C., & Bingham, E.A. (1995). Management of atopic eczema. British Medical Journal,310, 843–847.
407. Papadopoulos, L., Walker, C., Aitken, D., & Bor, R. (2000). The relationship between body location and psychological morbidity in individuals with acne vulgaris. Psychology Health and Medicine,5, 431–438.
408. Pauli-Pott, U., Dauri, A., & Beckmann, D. (1999). Infants with atopic dermatitis: maternal hopelessness, child-rearing attitudes and perceived infant temperament. Psychotherapy and Psycho- somatics,68, 39–45.
409. Richardson, J. (1997). Chapter ten. In: R. Lansdown, N. Rumsey, E. Bradbury, T. Carr, & J. Partridge (Eds), Visibly Different: Coping with Disfigurement. Oxford: ButterworthHeinmann.
410. Rogers, M., Fairely, M., & Santhanam, R. (2001). Artefactual skin disease in children and adolescents. The Australasian Journal of Dermatology, 42, 264–270.
411. Solomon, C.R., & Gagnon, C. (1987). Mother and child characteristics and involvement in dyads in which very young children have eczema. Developmental and Behavioural Paediatrics, 8, 213–220.
412. Schachner, L., Field, T., Hernandez, R.M., Duarte, A.M., & Krasnegor, J. (1998). Atopic dermatitis symptoms decreased in children following massage therapy. Pediatric Dermatology, 15, 390–395.
413. Sigelman, C.K., Miller, T.E., & Whitworth, L.A. (1986). The early development of stigmatising reaction to physical differences. Journal of Applied Developmental Psychology,7, 17–32.
414. Sloper, P. (2000). Predictors of distress in parents of children with cancer: a prospective study. Journal of Pediatric Psychology,25, 79–91.
415. Smith, J.A. (2001). The impact of skin disease on the quality of life of adolescents. Adolescent Medicine, 12, 343–353.
416. Smithard, A., Glazebrook, C., & Williams, H. (2001). Acne prevalence, knowledge about acne and psychological morbidity in mid adolescence: a community based study. British Journal of Dermatology,145, 274–279.
417. Stangier, U., & Ehlers, A. (2000). Stress and anxiety in dermatological disorders. In: D.I. Mostofsky, & D.H. Barlow (Eds), The Management of Stress and Anxiety in Medical Disorders. Needham Heights, MA: Allyn and Bacon, pp. 304–333.
418. Titman, P. (2003). Understanding Childhood Eczema. Chichester: John Wiley and Sons.
419. Wallander, J.L., & Varni, J.W. (1998). Effects of pediatric chronic physical disorders on child and family adjustment. Journal of Child Psychology and Psychiatry,39, 29–46.
420. Walters, E. (1997). Problems faced by children and families living with visible difference. In: R. Lansdown, N. Rumsey, E. Bradbury, T. Carr, & J. Partridge (Eds), Visibly Different: Coping with Disfigurement. Oxford: Butterworth-Heinmann.
421. Warschburger, P., Buchholz, H. Th., & Petermann, F. (2004). Psychological adjustment in parents of young children with atopic dermatitis: which factors predict parental quality of life? British Journal of Dermatology,150, 304–311.
422. Al-Abadie, M.S., Kent, G.G., & Gawkrodger, D.J. (1994). The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions. British Journal of Dermatology, 130, 199–203.
423. Barber, T.X. (1978). Hypnosis, suggestions and psychosomatic phenomena: a new look from the stand point of recent experimental studies. American Journal of Clinical Hypnosis, 21, 113–127.
424. Beck, A. (1976). Cognitive Therapy and Emotional Disorders. New York: International Universities Press.
425. Beck, A. (1993). Cognitive therapy: past, present and future. Journal of Consulting and Clinical Psychology, 61, 194–198.
426. Cole, W.C., Roth, H.L., & Sachs, L.B. (1988). Group psychotherapy as an aid in the medical treatment of eczema. Journal of the American Academy of Dermatology, 18(2), 286–291.
427. Ehlers, A., Stangier, U., & Gieler, U. (1995). Treatment of atopic dermatitis: a comparison of psychological and dermatological approaches to relapse prevention. Journal of Consulting and Clinical Psychology, 63(4), 624–635.
428. Fortune, D.G., Richards, H.L., Main, C.J., & Griffiths, C.E.M. (2000). Pathological worrying illness perceptions and disease severity in patients with psoriasis. British Journal of Health Psychology, 5, 71–82.
429. Fortune, D.G., Richards, H.L., Griffiths, C.E.M., & Main, C.J. (2004). Targeting cognitive- behavioural therapy to patient’s implicit model of psoriasis: results from a patient preference controlled trial. British Journal of Clinical Psychology, 43, 65–82.114 Linda Papadopoulos
430. Fortune, D.G., Richards, H.L., Kirby, B., Bowcock, S., Main, C.J., & Griffiths, C.E.M. (2002). A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy. British Journal of Dermatology, 146,458–465.
431. Ginsburg, J.H. (1995). Psychological and psychophysiological aspects of psoriasis. Dermatologic Clinics, 13(4), 793–804.
432. Gray, S.G., & Lawlis, G.F. (1982). A case study of pruritic eczema treated by relaxation and imagery. Psychological Reports, 51, 627–633.
433. Griffiths, C.E.M., & Richards, H.L. (2001). Psychological influences in psoriasis. Clinical and Experimental Dermatology, 26, 338–342.
434. Gupta, M.A., Schork, N.J., Gupta, A.K., Kirkby, S., & Ellis, C.N. (1993). Suicidal ideation in psoriasis. International Journal of Dermatology, 32, 188–190.
435. Horne, D.J.L., White, A.E., & Varigos, G.A. (1989). A preliminary study of psychological therapy in the management of atopic eczema. British Journal of Medical Psychology, 62,241–248.
436. Hughes, J.E., Barraclough, B.M., Hamblin, L.G., & White, J.E. (1983). Psychiatric symptoms in dermatology patients. British Journal of Psychiatry, 143, 51–54.
437. Kellett, S., & Gilbert, P. (2001). Acne: A biopsychosocial and evolutionary perspective with a focus on shame. British Journal ofHealth Psychology, 6, 1–24.
438. Koblenzer, C.S. (1983). Psychosomatic concepts in dermatology. Archives of Dermatology, 119, 501–512.
439. Papadopoulos, L., & Bor, R. (1999). Psychological Approaches to Dermatology. Leicester, UK: BPS.
440. Papadopoulos, L., & Walker, C. (2003). Understanding Skin Problems: Acne, Eczema, Psoriasis and Related Conditions. West Sussex, UK: Wiley.
441. Papadopoulos, L., Bor, R., & Legg, C. (1999a). Psychological factors in cutaneous disease: an overview of research. Psychology, Health & Medicine, 4(2), 107–126.
442. Papadopoulos, L., Bor, R., & Legg, C. (1999b). Coping with the disfiguring effects of vitiligo: A preliminary investigation into the effects of cognitive-behavioural therapy. British Journal of Medical Psychology, 10, 385–396.
443. Papadopoulos, L., Bor, R., & Legg, C., & Hawk, J.LM. (1998). Impact of life events on the onset of vitiligo in adults: preliminary evidence for a psychological dimension in aetiology. Clinical and Experimental Dermatology, 23, 243–248.
444. Papadopoulos, L., Bor, R., Walker, C., Flaxman, P., & Legg, C. (2002). Different shades of meaning: Illness beliefs among vitiligo sufferers. Psychology, Health & Medicine, 7(4), 425–433.
445. Price, M.L., Mottahedin, I., & Mayo, P.R. (1991). Can psychotherapy help with psoriasis? Clinical and Experimental Dermatology, 16, 114–117.
446. Robinson, E., Rumsey, N., & Partridge, J. (1996). An evaluation of the impact of social interaction skills training for facially disfigured people. British Journal of Plastic Surgery, 49,281–289.
447. Seng, T.K., & Nee, T.S. (1997). Group therapy: A useful and supportive treatment for psoriasis patients. International Journal of Dermatology, 36(2), 110–112.
448. Thompson, A.R., & Kent, G. (2001). Adjusting to disfigurement: processes involved in dealing with being visibly different. Clinical Psychology Review, 21, 663–682.
449. Thompson, A.R., Kent, G., & Smith, J.A. (2002). Living with vitiligo: dealing with difference. British Journal ofHealth Psychology, 7, 213–225.
450. Van Moffaert, M. (1992). Psychodermatology: an overview. Psychotherapy & Psychosomatics, 58, 125–136.
451. Weinstein, M.Z. (1984). Psychosocial perspectives on psoriasis. Dermatologic Clinics, 2, 507.
452. Winchell, S.A., & Watts R.A. (1988). Relaxation therapies in the treatment of psoriasis and possible pathophysiologic mechanisms. Journal of the American Academy of Dermatology, 18, 101–104.
453. Wolpe, J. (1980). Behaviour therapy for psychosomatic disorders. Psychosomatics, 21, 379–385.
454. Zacharie, R., Oster, H., Bjerring, P., & Kragballe, K. (1996). Effects of psychologic intervention on psoriasis: A preliminary report. Journal of the American Academy of Dermatology, 34, 1008–1015.
455. Aftergut, K., Carmody, T., & Cruzm, P.R. (2001). Use of the HIV-DERMDEX quality-of-life instrument in HIV-infected patients with skin disease. International Journal of Dermatology, 40, 472–484.
456. Aghaei, S., Sodaifi, M., & Jafari, P., et al. (2004). DLQI scores in vitiligo: reliability and validity of the Persian version. BMC Dermatology, 4, 8.
457. Anderson, R.T., & Rajagopolan, R. (1997). Development and validation of a quality of life instrument for cutaneous diseases. Journal of the American Academy of Dermatology, 36, 41–50.
458. Augustin, M., Dieterle, W., & Zschocke, I., et al. (1997). Development and validation of a disease- specific questionnaire on the quality of life of patients with chronic venous insufficiency. VASA, 26,291–301.
459. Augustin, M., Lange, S., Wenninger, K., Seidenglanz, K., Am on, U. & Zschocke, I. (2004). Validation of a comprehensive Freiburg Life Quality Assessment (FLQA) core questionnaire and development of a threshold system. European Journal of Dermatology, 14, 107–113.
460. Balkrishnan, R., McMichael, A.J., & Camacho, F.T., et al. (2003). Development and validation of a health-related quality of life instrument for women with melasma. British Journal of Dermatology, 149, 572–577.
461. Committee on rating of mental and physical impairment; guides to evaluation of permanent impairment. (1970). Journal of American Medical Association, 211, 106–112.
462. Chen, S.C., Yeung, J., & Chren, M-M. (2002). Scalpdex a quality of life instrument for scalp dermatitis. Archives of Dermatology, 138, 803–807.
463. Chren, M-M, Lasek, R.J., Quinn, L.M., Mostow, E.N., & Zyzanski, S.J. (1996). Skindex, a quality- of-life measure for patients with skin disease: reliability, validity and responsiveness. Journal of Investigative Dermatology, 107, 707–713.
464. de Korte, J., Mombers, F.M.C., & Sprangers, M.A.G., et al. (2002). The suitability of quality of life questionnaires for psoriasis research: a systematic literature review. Archives ofDermatology, 138, 1221–1227.
465. de Korte, J., Sprangers, M.A.G., & Mombers, F.M.C., et al. (2004). Quality of life in patients with psoriasis: a systematic literature review. Journal of Investigative Dermatology Symposium Proceedings, 9, 140–147.
466. Dolte, K.S., Girman, C.J., & Hartmaier, S., et al. (2000). Development of a health-related quality of life questionnaire for women with androgenic alopecia. Clinical and Experimental Dermatology, 25, 637–642.
467. Finlay, A.Y. (1996a). Measures of the effect of severe atopic eczema on quality of life. Journal of the European Academy of Dermatology and Venereology, 7, 149–159.
468. Finlay, A.Y. (1996b). Measurement of disease activity and outcome in atopic dermatitis. British Journal of Dermatology, 135, 509–515.
469. Finlay, A.Y. (1997). Quality of life measurement in dermatology: a practical guide. British Journal of Dermatology, 136, 305–314.
470. Finlay, A.Y. (2005). Current severe psoriasis and the rule of tens. British Journal of Dermatology, 152, 861–867.
471. Finlay, A.Y., & Coles, E.C. (1995). The effect of severe psoriasis on the quality of life of 369 patients. British Journal of Dermatology, 132,236–244.
472. Finlay, A.Y., & Kelly, S.E. (1985). Psoriasis: an index of severity. Scottish Medical Journal, 30, 266.
473. Finlay, A.Y., & Kelly, S.E. (1987). Psoriasis - an index of disability. Clinical and Experimental Dermatology, 12, 8–11.
474. Finlay, A.Y., & Khan, G.K. (1994). Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clinical and Experimental Dermatology, 19,210–216.
475. Finlay, A.Y., & Ryan, T.J. (1996). Disability and handicap in dermatology. International Journal of Dermatology, 35, 305–311.
476. Finlay, A.Y., Khan, G.K., Luscombe, D.K., & Salek, M.S. (1990). Validation of Sickness Impact Profile and Psoriasis disability Index in psoriasis. British Journal of Dermatology, 123, 751–756.
477. Ganemo, A., Sjoden, P.O., & Johansson, E., et al. (2004). Health-related quality of life among patients with ichthyosis. European Journal of Dermatology, 14, 61–6.
478. Girman, C.J., Hartmaier, S., & Thiboutot, D., et al. (1996). Evaluating health-related quality of life in patients with facial acne: development of a self-administered questionnaire for clinical trials. Quality of Life Research, 5, 481–490.
479. Gupta, M.A., & Gupta, A.K. (1995). The Psoriasis Life Stress Inventory: a preliminary index of psoriasis-related stress. Acta Dermato-Venereologica, 75, 240–243.
480. Gupta, M.A., Johnson, A.M., & Gupta, A.K. (1998). The development of an acne quality of life scale: reliability, validity and relation to subjective acne severity in mild to moderate acne vulgaris. Acta Dermato-Venereologica (Stockh), 78, 451–456.
481. Holm, E.A., Esmann, S., & Jemec, G.B.E. (2004). Does visible atopic dermatitis affect quality of life more in women than in men? Gender Medicine, 1(2), 125–130.
482. Holme, S.A., Mann, I., Sharpe, J.L., Dykes, P.J., Lewis-Jones, M.S., & Finlay, A.Y. (2003). The Childrens’ Dermatology Life Quality Index: validation of the cartoon version. British Journal of Dermatology, 148, 285–290.
483. Hongbo, Y., Thomas, C.L., Harrison, M.A., Salek, M.S., & Finlay, A.Y. (2004). Translating the science of quality of life into practice: what do Dermatology Life Quality Index scores mean? British Journal of Dermatology, 151 (Suppl. 68), 46.
484. Jenner, N., Campbell, J., & Marks, R. (2004). Morbidity and cost of atopic eczema in Australia. Australasian Journal of Dermatology, 45, 16–22.
485. Kelly, S.E., & Finlay, A.Y. (1987). Psoriasis - an index of disability. Clinical and Experimental Dermatology, 12, 8–11.
486. Koller, M., & Lorenz, W. (2002). Quality of Life; a deconstruction for clinicians. Journal of the Royal Society of Medicine, 95,481–488.
487. Katagumpola, R.P., Hongbo, Y., & Finlay, A.Y. (2004). The relationship between patient-rated quality of life and clinicians’ management decisions in psoriasis - a prospective study. Journal of Investigative Dermatology, 123(2): A70.
488. Kirby, B., Fortune, D.G., & Bhushan, M., et al. (2000). The Salford Psoriasis Index: an holistic measure of psoriasis severity. British Journal of Dermatology, 142, 728–732.
489. Lawson, V., Lewis-Jones, M.S., Finlay A.Y., Reid, P., & Owens, R.G. (1998). The family impact of childhood atopic dermatitis: the Dermatitis Family Impact Questionnaire. British Journal of Dermatology, 138, 107–113.
490. Layton, A.M. (1994). Psychological assessment of skin disease. Interfaces in Dermatology, 1, 9–11.
491. Lennox, R.D., & Leahy, M.J. (2004). Validation of the Dermatology Life Quality Index as an outcome measure for urticaria-related quality of life. Annals of Allergy Asthma and Immunology, 93, 142–146.
492. Lewis, V.J., & Finlay, A.Y. (2004). Ten years experience of the Dermatology Life Quality Index (DLQI). Journal of Investigative Dermatology Symposium Proceedings, 9, 140–147.
493. Lewis, V.J., & Finlay, A.Y. (2004). Two decades’ experience of the Psoriasis Disability Index. Dermatology, 151(68), 50–51.
494. Lewis-Jones, M.S., & Finlay, A.Y. (1995). The Children’s Dermatology Life Quality Index (CDLQI): initial validation and practical use. British Journal of Dermatology, 132, 942–949.
495. Lewis-Jones, M.S., Finlay, A.Y., & Dykes, P.J. (2001). The Infants’ Dermatitis Quality of Life Index. British Journal of Dermatology, 144, 104–110.
496. Littenberg, B., Partilo, S., & Licata, A., et al. (2003). Paper standard gamble: the reliability of a paper questionnaire to assess utility. Medical Decision Making, 23,480–488.
497. Martin, A.R., Lookingbill, D.P., & Botek, A., et al. (2001). Health-related quality of life among patients with facial acne - assessment of a new acne-specific questionnaire. Clinical and Experimental Dermatology, 26, 380–385.
498. McKenna, S.P., Cook, S.A., & Whalley, D., et al. (2003). Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials. British Journal of Dermatology, 149, 323–331.
499. Meurer, M., Fartasch, M., & Albrecht, G., et al. (2004). Long-term efficacy and safety of pimecrolimus cream 1% in adults with moderate atopic dermatitis. Dermatology, 208, 365–372.
500. Morgan, M., McCreedy, R., Simpson, J., & Hay, R.J. (1997). Dermatology quality of life scales: a measure of the impact of skin diseases. British Journal of Dermatology, 136, 202–206.
501. Mork, C., Ozek, M., & Wahl, A.K. (2004). Treatment of leisure? Climate therapy of patients with psoriasis and psoriatic arthritis. Tidsskr Nor Laegeforen, 124, 60–62.
502. Motley, R.J., & Finlay A.Y. (1989). How much disability is caused by acne? Clinical and Experimental Dermatology, 14, 194–198.
503. Motley, R.J., & Finlay, A.Y. (1992). Practical use of a disability index in the routine management of acne. Clinical and Experimental Dermatology, 17, 1–3.
504. Nichol, M.B., Margoilies, J.E., Lippa, E., Rowe, M., & Quell, J. (1996). The application of multiple quality of life instruments in individuals with mild-to-moderate psoriasis. Pharmacoeconomics, 10, 644–653.
505. Robinson, H.M. (1973). Measurement of impairment and disability in dermatology. Archives of Dermatology, 108,207–209.
506. Sampogna, F., Sera, F., & Abeni, D., et al. (2004). Measures of clinical severity, quality of life, and psychological distress in patients with psoriasis: a cluster analysis. Journal of Investigative Dermatology, 122, 602–607.
507. Sartorius, N. (1993). A WHO method for the assessment of health-related quality of life. In: S.R. Walker, & R.M. Rosser (Eds.), Quality of Life Assessment: Key Issues in the 1990s. London: Kluwer Academic Publishers, pp. 201–207.
508. Schiffner, R., Schiffner-Rohe, J., Gerstenhauer, M., Hofstadter, F., Landthaler, M., & Stolz, W. (2003). Willingness to pay and time trade-off: sensitive to changes of quality of life in psoriasis patients. British Journal of Dermatology, 148, 1153–1160.
509. Szepietowski, J., Salomon, J., & Finlay, A.Y., et al. (2004). Dermatology Life Quality Index (DLQI): Polish version. Dermatologia Kliniczna, 6, 63–70.
510. Uttjek, M., Dufaker, M., & Nygren, L., et al. (2004). Determinants of quality of life in a psoriasis population in northern Sweden. Acta Dermato-Venereologica, 84, 37–43.
511. Wallenhammar, L-M., Nyfjall, M., & Lindberg, M., et al. (2004). Health-Related quality of life and hand eczema - a comparison of two instruments, including factor analysis. Journal of Investigative Dermatology, 122, 1381–1389.
512. Whalley, D., McKenna, S.P., & Dewar, A.L., et al. (2004). A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of life Index for Atopic Dermatitis (QoLIAD). British Journal of Dermatology, 150,274–283.
513. Whitmore, C.W. (1970). Cutaneous impairment, disability and rehabilitation. Cutis, 6, 106–112.
514. Won, C.H., Seo, P.G., & Park, Y.M., et al. (2004). A multicenter trial of the efficacy and safety of 0.03% tacrolimus ointment for atopic dermatitis in Korea. Journal of Dermatological Treatment, 15, 30–34.
515. Working Party. (2003). Report on The Enquiry into the Impact of Skin Diseases on People’s Lives. All Party Parliamentary Group on Skin, London.
516. World Health Organisation. (1980). International classification of impairments, disabilities, and handicaps. Geneva. www.ukdermatology.co.uk (2004) (accessed 9 October 2004).
517. Yazici, K., Baz, K., & Yazici, A.E., et al. (2004). Disease-specific quality of life is associated with anxiety and depression in patients with acne. JEADV, 18,435–439.
518. Zachariae, R., Zachariae, C., & Ibsen, H.H.W., et al. (2004). Psychological symptoms and quality of life of dermatology outpatients and hospitalised dermatology patients. Acta Dermato- Venereologica, 84, 205–212.
519. Zaghloul, S.S., & Goodfield, M.J.D. (2004a). Objective assessment of compliance with psoriasis treatment. Archives of Dermatology, 140,408–414.
520. Zaghloul, S.S., & Goodfield, M.J.D. (2004b). The influence of nurse education clinics as a supplementary technique on compliance in psoriasis. British Journal of Dermatology, 151(Suppl. 68), 51.
521. Zug, K.A., Littenberg, B., & Baughman, R.D., et al. (1995). Assessing the preferences of patients with psoriasis. Archives of Dermatology, 131, 561–568.
522. Affleck, C., Tenner, H., Croog, S., & Levine, S. (1997). Causal attribution, perceived benefits and morbidity after a heart attack: an 8-year study. Journal of Consulting and Clinical Psychology, 55, 29–35
523. Croyle, R.T. (1992). Appraisal of health threats: Cognition, motivation, and social comparison. Cognitive Therapy and Research, 16(2), 165–182.
524. Finlay, A.Y., Khan, G.K., Luscombe, D.K., & Salek, M.S. (1990). Validation of Sickness Impact Profile and Psoriasis Disability Index in psoriasis. British Journal of Dermatology, 123, 751–756.
525. Fortune, D.G., Main, C.J., O’Sullivan, T.M., & Griffiths, C.E.M. (1997). Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress. British Journal of Dermatology, 137, 755–760.
526. Fortune, D.G., Richards, H.L., Griffiths, E.M., & Main, C. (2002). Psychological stress, distress and disability in patients with psoriasis: consensus and variation in the contribution of illness perceptions, coping and alexithymia. British Journal of Clinical Psychology, 41, 157–174.
527. Fried, R.G. (2002). Non-pharmacologic Treatments in Psychodermatology.DermatologicClinics, 20(1), 177–185.
528. Grandfield, T., Thompson, A., & Turpin, G. (2004). An attitudinal study of responses to dermatitis using the implicit association test. Poster presented at the Annual British Psychological Society Conference, April, 2004.
529. Gray, S.G., & Lawlis, G.F. (1982). A case study of pruritic eczema treated by relaxation and imagery. Psychological Reports, 51, 627–633.
530. Linville, P.W. (1987). Self-complexity as a cognitive buffer against stress-related illness and depression. Journal of Personality and Social Psychology, 2(4), 663–676.
531. Lau, R.R., & Hartman, K.A. (1983).‘Common sense representations of common illnesses’. Health Psychology, 2(March), 167–185.
532. Leventhal, H., Nerenz, D.R., & Steele, D.J. (1984). Illness representations and coping with health threats. In: A. Baum, S.E. Taylor, & J.E. Singer (Eds), Handbook of Psychology and Health. Hillsdale, NJ: Erlbaum.
533. Leventhal, H., Benyamini, Y., Brownlee, S., Diefenbach, M., Leventhal, E.A., Patrik Miller, L., & Robitaille, C. (1997). Illness representations: Theoretical foundations. In: K.J. Petrie, & J.A. Weinman (Eds), Perceptions of Health and Illness. Amsterdam: Harwood Academic Publishers.
534. Papadopoulos, L., & Bor, R. (1999). Psychological Approaches to Dermatology. BPS Books. Leicester, England.
535. Papadopoulos, L., & Walker, C.J. (2003). Understanding Skin Problems. John Wiley & Sons Ltd. Chichester.
536. Papadopoulos, L., Bor, R., & Legg, C. (1999). Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive-behavioural therapy. British Journal of Medical Psychology, 72(3), 385–396.
537. Richardson, J. (1997). Chapter 10. In: R. Lansdown, N. Rumsey, E. Bradbury, T. Carr, & J. Partridge (Eds), Visibly Different: Coping with Disfigurement. Oxford: Butterworth-Heinmann.
538. Robinson, E., Rumsey, N., & Partridge, J.P. (1996). An evaluation of the impact of social interaction skills training for facially disfigured people. British Journal of Plastic Surgery, 49, 281–289.
539. Schober, R., & Lacroix, J.M. (1991). Lay illness models in the enlightenment and the 20th Century: Some historical lessons. In: J.A. Skelton, & R.T. Croyle (Eds), Mental Representations in Health and Illness. New York: Springer Verlag.
540. Updike, J. (1990). Self Consciousness Memoirs. London: Penguin Books.
541. Van Moffaert, M. (1992). Psychodermatology: an overview. Psychotherapy and Psychosomatics, 58, 125–136.
542. Walters, E. (1997). Problems faced by children and families living with visible difference. In: R. Lansdown, N. Rumsey, E. Bradbury, T. Carr, & J. Partridge (Eds), Visibly Different: Coping with Disfigurement. Oxford: Butterworth-Heinmann.
543. Walker, C., Papadopoulos, L., & Anthis, L. (2004). The IPQ as a reliable measure of illness beliefs for adult acne patients. Psychology, Health & Medicine (in press).
544. Weinman, J., Petrie, K.J., Moss-Morris, R., & Horne, R. (1996). The illness perception questionnaire: a new method for assessing the cognitive representation of illness. Psychology and Health, 11,431–445.
545. Wolpe, J. (1980). Behaviour therapy for psychosomatic disorders. Psychosomatics, 21, 379–385.